Fig. 3

Number of women with CST I at enrollment and after 4 months of treatment. In the probiotic group the difference between T4 and T0 is significant (p < 0.05), in the placebo group the difference is not significant.

Number of women with CST I at enrollment and after 4 months of treatment. In the probiotic group the difference between T4 and T0 is significant (p < 0.05), in the placebo group the difference is not significant.